Brought to you by 
Late-stage round brings in $27mm for LensAR
11 Oct 2013
Executive Summary
LensAR Inc. raised $27mm through a late-stage financing, believed to be its Series F round. Returning investors Aisling Capital, Florida Growth, and Florida Opportunity Funds participated. LensAR will use the new money to continue selling its refractive lasers for cataract surgery in countries throughout North America, Europe, Asia, and Latin America.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Late-stage round brings in $27mm for LensAR
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice